Genmab — November 2018
-
7 uger? Det jeg kan se er at sgen fik godkendelse 2 uger efter færdiggørelsen af ansøgningen. I den skematiske tidsplan her er det så 2 uger efter uge 16. https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/OCE/ucm612927.htm
-
The new process, known as the Real-Time Oncology Review (RTOR) program, allows the agency to access key data prior to the official submission of the application, the FDA explained in a press release.This allows the review team "to begin their review earlier and communicate with the sponsor prior to the application's actual submission," said Richard Pazdur, MD, director of the FDA's Oncology Center of Excellence and acting director of the Office of Hematology and Oncology
-
When the sponsor submits the completed application, the review team will already be familiar with the data and be able to conduct a more efficient, timely and thorough review," he continued.In this case, the RTOR enabled the FDA to approve this indication within 2 weeks, he added.The new process was launched in July. Brentuximab is the fourth approval to emerge from the RTOR, noted the manufacturer.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind